首页> 美国卫生研究院文献>Annals of Hepato-Biliary-Pancreatic Surgery >First experience of pancreaticoduodenectomy using Revo-i in a patient with insulinoma
【2h】

First experience of pancreaticoduodenectomy using Revo-i in a patient with insulinoma

机译:使用Revo-i进行胰十二指肠切除术在胰岛素瘤患者中的初步经验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Robotic surgery systems have been developed to overcome the limitations of laparoscopic surgery. Recently, Meerecompany Inc. in Korea successfully manufactured a robotic surgical system called Revo-i. A 65-year old woman was referred for a pancreatic head tumor, detected as an incidental finding during a routine check-up. Contrast abdominopelvic CT revealed a pancreatic uncinate tumor measuring around 13 mm in diameter, with no other focal lesions. The patient underwent a robot-assisted pancreaticoduodenectomy (laparoscopic resection and robotic reconstruction) using Revo-i. The patient's recovery was uneventful and discharged on postoperative day 7. Our case showed the technical feasibility of the Korean robotic surgical system Revo-i. Further experiences are mandatory to validate this finding.
机译:已经开发出机器人手术系统来克服腹腔镜手术的局限性。最近,韩国的Meerecompany Inc.成功地制造了一种称为Revo-i的机器人手术系统。一名65岁的妇女因胰头瘤而被转诊,在常规检查中被发现为偶然发现。腹部骨盆CT扫描显示胰腺癌性肿瘤,直径约13毫米,无其他局灶性病变。患者使用Revo-i进行了机器人辅助的胰十二指肠切除术(腹腔镜切除和机器人重建)。患者的康复情况良好,术后第7天出院。我们的病例显示了韩国机器人手术系统Revo-i的技术可行性。必须有进一步的经验才能证实这一发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号